Novo Nordisk tests own mobile app in phase III trial with insulin hope
-go.jpg)
Novo Nordisk has started testing a hitherto-unknown app for people's phones which will help diabetes patients find their recommended doses based on their blood sugar levels and the insulin doses that they have already ingested, according to a report for the database Clinical Trials, which gathers info on clinical trials.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app